Australia markets closed

VTGN Nov 2024 5.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.30000.0000 (0.00%)
As of 11:37AM EDT. Market open.
Full screen
Previous close0.3000
Open0.3500
Bid0.0000
Ask0.0000
Strike5.00
Expiry date2024-11-15
Day's range0.3000 - 0.3500
Contract rangeN/A
Volume16
Open interest65
  • Simply Wall St.

    Vistagen Therapeutics Full Year 2024 Earnings: EPS Beats Expectations

    Vistagen Therapeutics ( NASDAQ:VTGN ) Full Year 2024 Results Key Financial Results Net loss: US$29.4m (loss narrowed by...

  • Insider Monkey

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript

    VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript June 11, 2024 Operator: Greetings, and welcome to the Vistagen Therapeutics Fiscal Year-End 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. […]

  • Business Wire

    Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

    SOUTH SAN FRANCISCO, Calif., June 11, 2024--Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today reported financial results for its fiscal year ended March 31, 2024, and provided a corporate update.